clodronic acid has been researched along with Colorectal Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Han, W; Han, Y; Liu, Y; Lou, J; Pan, H; Sun, J; Yang, Y; Yao, J | 1 |
| Bader, JE; Carson, JA; Carson, MS; Chatzistamou, I; Davis, JM; Enos, RT; Murphy, EA; Nagarkatti, M; Nagarkatti, PS; Robinson, CM; Velázquez, KT | 1 |
| Benner, A; Berthel, A; Brand, K; Buechler, MW; Falk, CS; Grabe, N; Halama, N; Herrmann, T; Jaeger, D; Kahlert, C; Klupp, F; Koch, M; Krauss, J; Kunz, C; Lasitschka, F; Lerchl, T; Luckner-Minden, C; Luecke, S; Schneider, M; Springfeld, C; Suarez-Carmona, M; Suetterlin, T; Ulrich, A; Weitz, J; Zitvogel, L; Zoernig, I | 1 |
3 other study(ies) available for clodronic acid and Colorectal Neoplasms
| Article | Year |
|---|---|
TMP195 Exerts Antitumor Effects on Colorectal Cancer by Promoting M1 Macrophages Polarization.
Topics: Animals; Cell Line, Tumor; Clodronic Acid; Colorectal Neoplasms; Cytokines; Histone Deacetylase Inhibitors; Histone Deacetylases; Liposomes; Macrophages; Mice; Programmed Cell Death 1 Receptor | 2022 |
Macrophage depletion using clodronate liposomes decreases tumorigenesis and alters gut microbiota in the AOM/DSS mouse model of colon cancer.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Biomarkers, Tumor; Cell Transformation, Neoplastic; Clodronic Acid; Colon; Colonic Polyps; Colorectal Neoplasms; Cytokines; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Host-Pathogen Interactions; Inflammation Mediators; Liposomes; Macrophages; Male; Mice, Inbred C57BL; Signal Transduction; Time Factors; Tumor Burden | 2018 |
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients.
Topics: Adenocarcinoma; Apoptosis; Chemokine CCL5; Chemokines; Chemotaxis; Clinical Trials, Phase I as Topic; Clodronic Acid; Colorectal Neoplasms; Cyclohexanes; Humans; Interferon-alpha; Liver Neoplasms; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Macrophages; Maraviroc; Molecular Targeted Therapy; Neoplasm Invasiveness; Neoplasm Proteins; NG-Nitroarginine Methyl Ester; Phenylurea Compounds; Pilot Projects; Pyridines; Receptors, CCR5; STAT3 Transcription Factor; Survival Analysis; Triazoles; Tumor Cells, Cultured; Tumor Microenvironment | 2016 |